资讯

Caribou Biosciences to Participate in the BofA Securities 2025 Health Care Conference
BERKELEY, Calif., May 06, 2025 (GLOBE NEWSWIRE) -- (Nasdaq: CRBU), a leading clinical-stage CRISPR genome-editing biopharmaceutical company, today announced Rachel Haurwitz, PhD, Caribou’s president ...